Provided by Tiger Trade Technology Pte. Ltd.

Biocryst Pharmaceuticals

7.31
+0.35505.11%
Volume:1.33M
Turnover:9.61M
Market Cap:1.81B
PE:-161.19
High:7.36
Open:6.97
Low:6.97
Close:6.95
52wk High:11.31
52wk Low:6.00
Shares:248.00M
Float Shares:218.00M
Volume Ratio:0.89
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0453
EPS(LYR):-0.4300
ROE:587.33%
ROA:10.31%
PB:-4.67
PE(LYR):-16.99

Loading ...

Jan 23, 2026

Major Issues Report

Form 8-K - Current report
Jan 23, 2026

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 09, 2026

Major Issues Report

Form 8-K - Current report
Dec 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2025

Major Issues Report

Form 8-K - Current report
Dec 03, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Dec 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2025

Major Issues Report

Form 8-K - Current report
Oct 14, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Oct 14, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations